Abstract
Background: Streptokinase, one of the most widely used thrombolytic medicines, is a favorable protein for site-specific PEGylation as it lacks any cysteine residues in its amino acid sequence; however, any changes in the protein’s structure should be carefully planned to avoid undesired changes in its function.
Objectives: This study aimed to design and produce novel di/tri-cysteine variants of streptokinase from previously developed cysteine analogues, Arg45, Glu263, and Arg319, as candidates for multiple site-specific PEGylation.
Methods: Using bioinformatics tools and site-directed mutagenesis, we incorporated concurrent mutations at Arg45, Glu263, and Arg319 (carried out in our previous study) to create di/tri-cysteine variants of streptokinase proteins (SK45-319cys, SK263-319cys, and SK45-263-319cys) and evaluated their kinetic activity parameters by a colorimetric method, using H-D-Val-Leu-Lys-pNA.2HCl (S2251) as substrate.
Results: Based on the kinetic results, SK263-319cys with 44% enzyme efficiency increment compared to wild-type SK was the superior protein in terms of activity; as well, SK45-319cys and SK45-263-319cys showed 17 and 22% activity enhancement, respectively. Docking of the mutant streptokinase proteins with μ-plasmin demonstrated that changes in intermolecular interactions caused by amino acid substitution could be the reason for activity difference.
Conclusion: The novel mutant proteins created in this study exhibit remarkable biological activity and may be uniquely suitable for simultaneous PEGylation on two/three domains. As well, PEGylated derivates of these variants might prove to be more proficient proteins, compared to the singlecysteine analogs of streptokinase; because of their more surface coverage and increased molecular weight.
Keywords: Streptokinase, plasminogen, site directed mutagenesis, cysteine, activity, docking.
[http://dx.doi.org/10.1016/j.biotechadv.2003.09.004] [PMID: 14697452]
[http://dx.doi.org/10.1073/pnas.81.11.3557] [PMID: 6374659]
[http://dx.doi.org/10.1007/BF00328072] [PMID: 6593564]
[http://dx.doi.org/10.1016/j.vph.2005.09.003] [PMID: 16275118]
[http://dx.doi.org/10.2174/187152571103140120103816] [PMID: 23531210]
[http://dx.doi.org/10.1161/01.CIR.94.6.1233] [PMID: 8822974]
[http://dx.doi.org/10.1136/emj.16.6.407] [PMID: 10572811]
[http://dx.doi.org/10.1089/jir.2012.0148] [PMID: 23962003]
[http://dx.doi.org/10.1210/en.2006-1170] [PMID: 17234711]
[http://dx.doi.org/10.1021/bc050172r] [PMID: 16173810]
[http://dx.doi.org/10.1007/978-1-62703-977-2_37] [PMID: 24648098]
[http://dx.doi.org/10.1371/journal.pone.0155831] [PMID: 27192220]
[http://dx.doi.org/10.2174/1381612822666160204120547] [PMID: 26845325]
[http://dx.doi.org/10.2174/1389201020666190208155808] [PMID: 30734674]
[http://dx.doi.org/10.33073/pjm-2011-034] [PMID: 22184932]
[http://dx.doi.org/10.1073/pnas.96.16.8879] [PMID: 10430864]
[http://dx.doi.org/10.1016/S0022-1759(02)00435-0] [PMID: 12505715]
[http://dx.doi.org/10.1002/pro.5560050414] [PMID: 8845759]
[http://dx.doi.org/10.1126/science.281.5383.1662] [PMID: 9733510]
![Wayfinder Image](/images/wayfinder.jpg)